Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms

British Journal of Cancer

Volumn 108, Issue 4, 2013, Pages 951-958

  Nishikawa, G ^a   Sekine, S ^b   Ogawa, R ^b   Matsubara, A ^a   Mori, T ^b   Taniguchi, H ^a   Kushima, R ^a   Hiraoka, N ^b   Tsuta, K ^a   Tsuda, H ^a   Kanai, Y ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

GNAS; KRAS; low grade mucinous appendiceal neoplasm

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; K RAS PROTEIN; MUCIN 2; MUCIN 5AC;

ADENOCARCINOMA; ADULT; AGED; ANIMAL EXPERIMENT; APPENDIX TUMOR; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CELL GROWTH; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LOW GRADE APPENDICEAL MUCINOUS NEOPLASM; MALE; MOUSE; MUCINOUS ADENOCARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APPENDICEAL NEOPLASMS; FEMALE; GENES, RAS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MUTATION; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875228843     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.47     Document Type: Article

References (28)

1. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Juppner H, Kronenberg HM, Chung UI (2004) Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci USA 101(41): 14794-14799.
2. Carr NJ, Arends MJ, Deans GT, Sobin LH (2000) Adenocarcinoma of the appendix, WHO Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IRAC Press: Lyon, pp 95-98.
3. Carr NJ, Emory TS, Sobin LH (2002) Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2. Arch Pathol Lab Med 126(7): 837-841.
4. Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, Cecil T, Moran B (2012) Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol 65(10): 919-923.
5. Carr NJ, McCarthy WF, Sobin LH (1995) Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer 75(3): 757-768.
6. Carr NJ, Sobin LH (2010) Adenocarcinoma of the appendix. WHO Classification of Tumours of the Digestive System, 4th Edition, IRAC Press: Lyon, pp 122-128.
7. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gomez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonzalez-Moreno S, Van Der Speeten K, Morris DL (2012) Early-and longterm outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20): 2449-2456.
8. Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N, Shiratori K (2011) Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1: 161.
9. Hokari R, Lee H, Crawley SC, Yang SC, Gum Jr. JR, Miura S, Kim YS (2005) Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. Am J Physiol Gastrointest Liver Physiol 289(5): G949-G959.
10. Kabbani W, Houlihan PS, Luthra R, Hamilton SR, Rashid A (2002) Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol 15(6): 599-605.
11. Laburthe M, Augeron C, Rouyer-Fessard C, Roumagnac I, Maoret JJ, Grasset E, Laboisse C (1989) Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E. Am J Physiol 256 (3 Pt 1): G443-G450.
12. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340(6236): 692-696.
13. Lee SH, Jeong EG, Soung YH, Lee JW, Yoo NJ (2008) Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 40(1): 95-97.
14. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249(4969): 655-659.
15. Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, Kanai Y (2012) Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol; e-pub ahead of prime 3 December 2012; doi:10.1002/path.4153.
16. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG (2005) Longterm survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241(2): 300-308.
17. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27(8): 1089-1103.
18. Nielsen GP, Isaksson HJ, Finnbogason H, Gunnlaugsson GH (1991) Adenocarcinoma of the vermiform appendix. A population study. APMIS 99(7): 653-656.
19. Panarelli NC, Yantiss RK (2011) Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med 135(10): 1261-1268.
20. Sekine S, Ogawa R, Kanai Y (2011) Hepatomas with activating Ctnnb1 mutations in 'Ctnnb1-deficient' livers: a tricky aspect of a conditional knockout mouse model. Carcinogenesis 32(4): 622-628.
21. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34(2): 196-201.
22. Song KS, Choi YH, Kim JM, Lee H, Lee TJ, Yoon JH (2009) Suppression of prostaglandin E2-induced MUC5AC overproduction by RGS4 in the airway. Am J Physiol Lung Cell Mol Physiol 296(4): L684-L692.
23. Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM (1999) Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol 154(6): 1849-1855.
24. Thomas RM, Sobin LH (1995) Gastrointestinal cancer. Cancer 75(1 Suppl): 154-170.
25. Velcich A, Augenlicht LH (1993) Regulated expression of an intestinal mucin gene in HT29 colonic carcinoma cells. J Biol Chem 268(19): 13956-13961.
26. Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, Wolfgang CL, Klein AP, Diaz Jr. LA, Allen PJ, Schmidt CM, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B (2011) Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 3(92): 92ra66.
27. Yamada M, Sekine S, Ogawa R, Taniguchi H, Kushima R, Tsuda H, Kanai Y (2012) Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol 228(1): 113-118.
28. Zauber P, Berman E, Marotta S, Sabbath-Solitare M, Bishop T (2011) Ki-ras gene mutations are invariably present in low-grade mucinous tumours of the vermiform appendix. Scand J Gastroenterol 46(7-8): 869-874.